Loading...

FGFR1 underlies obesity-associated progression of estrogen receptor–positive breast cancer after estrogen deprivation

Obesity increases breast cancer mortality by promoting resistance to therapy. Here, we identified regulatory pathways in estrogen receptor–positive (ER-positive) tumors that were shared between patients with obesity and those with resistance to neoadjuvant aromatase inhibition. Among these was fibro...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JCI Insight
Main Authors: Wellberg, Elizabeth A., Kabos, Peter, Gillen, Austin E., Jacobsen, Britta M., Brechbuhl, Heather M., Johnson, Stevi J., Rudolph, Michael C., Edgerton, Susan M., Thor, Ann D., Anderson, Steven M., Elias, Anthony, Zhou, Xi Kathy, Iyengar, Neil M., Morrow, Monica, Falcone, Domenick J., El-Hely, Omar, Dannenberg, Andrew J., Sartorius, Carol A., MacLean, Paul S.
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Clinical Investigation 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6124402/
https://ncbi.nlm.nih.gov/pubmed/30046001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.120594
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!